Familial backgrounds and risk behaviors of youth with thrownaway experiences.

PubWeight™: 1.78‹?› | Rank: Top 3%

🔗 View Article (PMID 9657892)

Published in J Adolesc on June 01, 1998

Authors

C L Ringwalt1, J M Greene, M J Robertson

Author Affiliations

1: Research Triangle Institute, Research Triangle Park, NC 27709-2194, USA.

Associated clinical trials:

Engaging Seronegative Youth to Optimize HIV Prevention Continuum | NCT03134833

Articles citing this

The Everyday Violence of Hepatitis C Among Young Women Who Inject Drugs in San Francisco. Hum Organ (2004) 2.71

Pro-social and problematic social network influences on HIV/AIDS risk behaviours among newly homeless youth in Los Angeles. AIDS Care (2007) 1.83

Homelessness and drug abuse among young men who have sex with men in New York city: a preliminary epidemiological trajectory. J Adolesc (2005) 1.73

Characteristics of natural mentoring relationships from the perspectives of homeless youth. J Child Adolesc Psychiatr Nurs (2013) 1.38

Substance use and other risk factors for unprotected sex: results from an event-based study of homeless youth. AIDS Behav (2012) 1.20

Adolescents Exiting Homelessness Over Two Years: The Risk Amplification and Abatement Model. J Res Adolesc (2009) 1.17

Runaway and pregnant: risk factors associated with pregnancy in a national sample of runaway/homeless female adolescents. J Adolesc Health (2008) 1.13

Drug use among homeless young people in Los Angeles and Melbourne. J Adolesc Health (2008) 1.06

Individual and structural vulnerability among female youth who exchange sex for survival. J Adolesc Health (2011) 1.04

Increased substance use and risky sexual behavior among migratory homeless youth: exploring the role of social network composition. J Youth Adolesc (2011) 1.02

Interventions to modify sexual risk behaviours for preventing HIV in homeless youth. Cochrane Database Syst Rev (2011) 0.98

The challenge of pregnancy among homeless youth: reclaiming a lost opportunity. J Health Care Poor Underserved (2010) 0.92

WHO IS DOING WELL? A TYPOLOGY OF NEWLY HOMELESS ADOLESCENTS. J Community Psychol (2009) 0.90

Relationship Between Service Utilization and Runaway Youths' Alcohol and Other Drug Use. Alcohol Treat Q (2001) 0.86

The Social Networks of Homeless Youth Experiencing Intimate Partner Violence. J Interpers Violence (2014) 0.80

Physical and Mental Health Issues among Homeless Youth in British Columbia, Canada: Are they Different from Older Homeless Adults? J Can Acad Child Adolesc Psychiatry (2014) 0.79

The Effects of Runaway-Homeless Episodes on High School Dropout. Youth Soc (2015) 0.79

Propensity for Violence among Homeless and Runaway Adolescents: An Event History Analysis* Crime Delinq (2009) 0.78

Peer Relationships: Comparison of homeless youth in the U.S. and South Korea. Int Soc Work (2007) 0.78

Discrimination and mental health problems among homeless minority young people. Public Health Rep (2010) 0.76

Educating Homeless Youth in Texas: The McKinney-Vento Homeless Education Assistance Improvements Act of 2001. Educ Real (2008) 0.75

Violence, Trauma, Mental Health, and Substance Use Among Homeless Youth Juggalos. Child Psychiatry Hum Dev (2016) 0.75

Sexual risk, substance use, mental health, and trauma experiences of gang-involved homeless youth. J Adolesc (2016) 0.75

Early life circumstances as contributors to HIV infection. Soc Work Health Care (2014) 0.75

Articles by these authors

The prevalence of homelessness among adolescents in the United States. Am J Public Health (1998) 4.07

Cryptic branch point activation allows accurate in vitro splicing of human beta-globin intron mutants. Cell (1985) 3.25

Diagnostic electron microscopy of faeces. II. Acute gastroenteritis associated with reovirus-like particles. J Clin Pathol (1974) 2.33

Cutting edge: IL-17F, a novel cytokine selectively expressed in activated T cells and monocytes, regulates angiogenesis and endothelial cell cytokine production. J Immunol (2001) 2.28

Life-styles, adaptive strategies, and sexual behaviors of homeless adolescents. Hosp Community Psychiatry (1993) 2.28

Activation and repression of mammalian gene expression by the c-myc protein. Genes Dev (1987) 2.26

Bortezomib in patients with relapsed or refractory mantle cell lymphoma: updated time-to-event analyses of the multicenter phase 2 PINNACLE study. Ann Oncol (2008) 2.23

Selective modulation of human natural killer cells in vivo after prolonged infusion of low dose recombinant interleukin 2. J Clin Invest (1993) 2.18

Effects of cannabis on lung function: a population-based cohort study. Eur Respir J (2009) 2.16

Health status and access to health services among the urban homeless. Am J Public Health (1986) 2.15

Efficient retrovirus-mediated transfer of the multidrug resistance 1 gene into autologous human long-term repopulating hematopoietic stem cells. Nat Med (2000) 2.09

Phase I evaluation of intravenous recombinant human interleukin 12 in patients with advanced malignancies. Clin Cancer Res (1997) 2.08

Vi reaction in Hong Kong. Br Med J (1967) 1.85

Patterns of adherence to diabetes vision care guidelines: baseline findings from the Diabetic Retinopathy Awareness Program. Ophthalmology (2001) 1.70

Sarcoidosis and common variable immunodeficiency. Report of 8 cases and review of the literature. Medicine (Baltimore) (1996) 1.53

Brown-Séquard syndrome in a patient with systemic lupus erythematosus. Neurology (1990) 1.38

Synovitis of the knee in a 42-year-old man. Arthritis Rheum (1993) 1.38

Associations between birth weight, early childhood weight gain and adult lung function. Thorax (2008) 1.35

Interleukin 2 signaling involves the phosphorylation of Stat proteins. Proc Natl Acad Sci U S A (1995) 1.32

Can the poor adhere? Incentives for adherence to TB prevention in homeless adults. Int J Tuberc Lung Dis (2004) 1.31

P2Y1-receptors in human platelets which are pharmacologically distinct from P2Y(ADP)-receptors. Br J Pharmacol (1998) 1.30

Expression of sialyl-Lewis X, an E-selectin ligand, in inflammation, immune processes, and lymphoid tissues. Am J Pathol (1992) 1.29

CD69 is a stimulatory receptor for natural killer cell and its cytotoxic effect is blocked by CD94 inhibitory receptor. Immunology (1999) 1.26

Inhibition of selective signaling events in natural killer cells recognizing major histocompatibility complex class I. Proc Natl Acad Sci U S A (1995) 1.25

Interleukin 2 receptor gamma chain expression on resting and activated lymphoid cells. J Exp Med (1994) 1.25

Recruiting participants for community-based research: the Diabetic Retinopathy Awareness Program. Ann Epidemiol (2000) 1.23

Developmental regulation of a mucinlike glycoprotein selectively expressed on natural killer cells. J Exp Med (1993) 1.20

Evidence for urinary excretion of glucuronide conjugates of nicotine, cotinine, and trans-3'-hydroxycotinine in smokers. Drug Metab Dispos (1992) 1.13

Discordant phenotype in siblings with X-linked agammaglobulinemia. Am J Hum Genet (1996) 1.12

Cloning of BY55, a novel Ig superfamily member expressed on NK cells, CTL, and intestinal intraepithelial lymphocytes. J Immunol (1998) 1.09

Relationship between socioeconomic status and asthma: a longitudinal cohort study. Thorax (2004) 1.05

Interleukin-18: biology and role in the immunotherapy of cancer. Curr Med Chem (2010) 1.03

Participation of the CD27 antigen in the regulation of IL-2-activated human natural killer cells. J Immunol (1992) 1.03

Differential responses to interleukin 2 define functionally distinct subsets of human natural killer cells. Eur J Immunol (1992) 1.02

Retrospective analysis of the incidence of pulmonary disease in hypogammaglobulinemia. J Allergy Clin Immunol (1991) 1.02

A single strand conformation polymorphism study of CD40 ligand. Efficient mutation analysis and carrier detection for X-linked hyper IgM syndrome. J Clin Invest (1996) 1.00

A novel series of P2T purinoceptor antagonists: definition of the role of ADP in arterial thrombosis. Trends Pharmacol Sci (1995) 0.99

Synthesis and antimicrobial evaluation of dirithromycin (AS-E 136; LY237216), a new macrolide antibiotic derived from erythromycin. Antimicrob Agents Chemother (1991) 0.99

Synthesis and structure-activity relationships of new 9-N-alkyl derivatives of 9(S)-erythromycylamine. J Med Chem (1990) 0.99

Prevention of graft-versus-host disease by selective depletion of CD6-positive T lymphocytes from donor bone marrow. J Clin Oncol (1992) 0.97

Cancer screening in homeless women: attitudes and behaviors. J Health Care Poor Underserved (1998) 0.96

ADP can induce aggregation of human platelets via both P2Y(1) and P(2T) receptors. Br J Pharmacol (2000) 0.96

Fc gamma RIIIA-mediated signaling involves src-family lck in human natural killer cells. J Immunol (1993) 0.95

Pulmonary oedema after the administration of intravenous salbutamol and ergometrine. Case report. Br J Obstet Gynaecol (1980) 0.95

Hepatitis B among homeless and other impoverished US military veterans in residential care in Los Angeles. Public Health (2001) 0.94

The actions of dopamine and of sulpiride on regional blood flows in the rat kidney. J Physiol (1980) 0.94

Participation of the CD94 receptor complex in costimulation of human natural killer cells. J Immunol (1998) 0.93

Immunosuppression induced by attenuated Salmonella: effect of LPS responsiveness on development of suppression. Microb Pathog (1992) 0.92

Role of angiotensin AT1 and AT2 receptors in mediating the renal effects of angiotensin II in the anaesthetized dog. Br J Pharmacol (1993) 0.91

Autologous bone marrow transplantation in poor-prognosis intermediate-grade and high-grade B-cell non-Hodgkin's lymphoma in first remission: a pilot study. J Clin Oncol (1993) 0.91

Phase I trial and pharmacokinetic study of high-dose clofarabine and busulfan and allogeneic stem cell transplantation in adults with high-risk and refractory acute leukemia. Leukemia (2011) 0.91

Prediction of graft-versus-host disease by phenotypic analysis of early immune reconstitution after CD6-depleted allogeneic bone marrow transplantation. Blood (1993) 0.90

Human geranylgeranyl diphosphate synthase: isolation of the cDNA, chromosomal mapping and tissue expression. J Lipid Res (1998) 0.90

Interleukin-12 augments cytolytic activity of peripheral blood lymphocytes from patients with hematologic and solid malignancies. Blood (1993) 0.90

High-dose therapy and autologous bone marrow transplantation in patients with follicular lymphoma during first remission. Blood (1996) 0.89

Amniotic fluid phosphatidylglycerol in diabetic pregnancies. Am J Obstet Gynecol (1978) 0.89

Expression of CD95 antigen and Bcl-2 protein in non-Hodgkin's lymphomas and Hodgkin's disease. Am J Pathol (1996) 0.89

Sources of income among homeless adults with major mental disorders or substance use disorders. Psychiatr Serv (1996) 0.88

Long-term disease-free survival after nonmyeloablative cyclophosphamide/fludarabine conditioning and related/unrelated allotransplantation for acute myeloid leukemia/myelodysplasia. Bone Marrow Transplant (2010) 0.87

Role of the CD40 and CD95 (APO-1/Fas) antigens in the apoptosis of human B-cell malignancies. Br J Haematol (1997) 0.87

Plasma ascorbic acid concentrations relate inversely to blood pressure in human subjects. Am J Clin Nutr (1993) 0.86

Characterization of the glucuronide conjugate of cotinine: a previously unidentified major metabolite of nicotine in smokers' urine. Chem Res Toxicol (1992) 0.86

Phosphorylation of src family lck tyrosine kinase following interleukin-12 activation of human natural killer cells. Cell Immunol (1995) 0.85

Cholera case investigation and the detection and treatment of cholera carriers in Hong Kong. Bull World Health Organ (1968) 0.85

Outpatient management with oral corticosteroid therapy for obstructive conditions in chronic granulomatous disease. J Pediatr (1993) 0.83

A longitudinal perspective on entitlement income among homeless adults. Psychiatr Serv (1998) 0.83

A triplet of nuclease proteins (NP42-50) is activated in human Jurkat cells undergoing apoptosis. Cell Immunol (1995) 0.83

A prospective study of proximal femur bone mass following cemented and uncemented hip arthroplasty. J Bone Miner Res (1996) 0.83

Pharmacological effects of GR138950, a novel angiotensin AT1 receptor antagonist. J Pharmacol Exp Ther (1995) 0.83

The impact of childhood foster care and other out-of-home placement on homeless women and their children. Child Abuse Negl (1999) 0.83

Monoclonal antibody-purged bone marrow transplantation therapy for multiple myeloma. Blood (1993) 0.82

Renal blood-flow changes during renal nerve stimulation in rats treated with alpha-adrenergic and dopaminergic blockers. J Physiol (1982) 0.82

The nitrosation of nicotine: a kinetic study. Chem Res Toxicol (1992) 0.82

Relationship of ECMO duration with outcomes after pediatric cardiac surgery: a multi-institutional analysis. Minerva Anestesiol (2014) 0.82

Macrophage activation syndrome and other systemic inflammatory conditions after BMT. Bone Marrow Transplant (2006) 0.81

Dopamine receptor blockade in the rat kidney [proceedings]. J Physiol (1978) 0.81

Flt3 ligand antitumor activity in a murine breast cancer model: a comparison with granulocyte-macrophage colony-stimulating factor and a potential mechanism of action. Hum Gene Ther (1999) 0.81

Residency time, migration route and survival of Atlantic salmon Salmo salar smolts in a Canadian fjord. J Fish Biol (2011) 0.81

Performance and design of InGaAs /InP photodiodes for single-photon counting at 1.55 microm. Appl Opt (2000) 0.81

Reversal of morphine-induced catalepsy in the rat by narcotic antagonists and their quaternary derivatives. Neuropharmacology (1983) 0.80

Changes in renal blood flow in the rat during renal nerve stimulation: the effects of alphs-adrenergic blockers and a dopaminergic blocker [proceedings]. J Physiol (1979) 0.80

Cardiovascular effects of GR117289, a novel angiotensin AT1 receptor antagonist. Br J Pharmacol (1994) 0.80

Intragastric nitrosation of nicotine is not a significant contributor to nitrosamine exposure. Ann N Y Acad Sci (1993) 0.80

Creation of a regional medical-nutrition education network. Am J Clin Nutr (1989) 0.80

The depressor and renal vasodilator responses to dopamine in the rat do not depend on prostaglandin biosynthesis. J Pharm Pharmacol (1980) 0.79

Dopamine induced vasodilatation in the rat kidney [proceedings]. J Physiol (1978) 0.79

Concurrent validity of negative symptom assessments in treatment refractory schizophrenia: relationship between interview-based ratings and inpatient ward observations. J Psychiatr Res (2001) 0.79

Induction of cell death via Fas (CD95, Apo-1) may be associated with but is not dependent on Fas-induced tyrosine phosphorylation. Immunol Lett (1996) 0.79

Autologous transplantation of mobilized peripheral blood CD34+ cells selected by immunomagnetic procedures in patients with multiple myeloma. Bone Marrow Transplant (1998) 0.79

Isolation of ACTH responsive cells from rat adrenal cortex and the determination of the density of male and female cells. FEBS Lett (1979) 0.78

Effects of dopamine DA1-receptor blockade and angiotensin converting enzyme inhibition on the renal actions of fenoldopam in the anaesthetized dog. J Hypertens (1991) 0.78

Rapid modulation of T lymphocyte surface antigens induced by Fas (CD95, APO-1) ligation. Cell Immunol (1996) 0.78

CD94 ligation induces apoptosis in a subset of IL-2-stimulated NK cells. J Immunol (1997) 0.78

Vitamin A in hypercholesterolemia. Am J Med Sci (1992) 0.78

Distribution of membrane cholesterol of adrenal cortical cells after corticotropin stimulation. Biochem J (1983) 0.77

Autoimmune hemolytic anemia in chronic mucocutaneous candidiasis. Clin Diagn Lab Immunol (1994) 0.77

Chronic opiate treatment does not modify alpha 2-adrenergic receptors in rat cerebral cortex, kidney and in the neurotumor cell line NCB20. Eur J Pharmacol (1983) 0.76

Effect of bacterial endotoxin and inhibitors on tryptophan oxygenase induction in mouse liver slices. J Bacteriol (1968) 0.76

Molecular cloning of the canine angiotensin II receptor. An AT1-like receptor with reduced affinity for DuP753. FEBS Lett (1994) 0.76